Svanborg Cecilia, Wistedt Anna Aberg, Svanborg Pär
Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institute, St Göran's Hospital, Stockholm, Sweden.
Nord J Psychiatry. 2008;62(1):17-24. doi: 10.1080/08039480801960123.
The highly prevalent psychiatric disorders dysthymia and panic disorder have often a chronic or recurrent course with superimposed major depression. The prominent comorbidity between these diagnoses constitutes a confounding factor in the study of long-term outcome. We performed a 9-year follow-up of 38 patients with "pure" diagnoses, i.e. without comorbid dysthymia and panic disorder, selected from two 2-year naturalistic treatment studies with psychotherapy and antidepressant medication. The aims of the present study were to investigate 1) the stability of change, and 2) the impact of comorbid personality disorders (PDs) on long-term outcome. Patients were reassessed with SCID-I and SCID-II interviews, SCL-90/BSI and a detailed, modified life-charting interview, investigating course and treatment over time. About 50% of patients showed substantial improvement, of whom about half were in remission. Comorbid PD was a negative prognostic factor independently of Axis I diagnosis. Although patients with panic disorder had a lower frequency of comorbid PD, later onset, shorter duration of illness and better outcome after the original studies, there was no difference in the long-term outcome. The less stable outcome among panic patients suggests that standard treatments are not resulting in enduring remission. In order to achieve remission, it is necessary to 1) address comorbid PDs, 2) perform careful assessments of all comorbid diagnoses, and 3) build routines for the follow-up and augmentation of treatments.
高度流行的精神障碍恶劣心境和惊恐障碍通常病程呈慢性或复发性,并伴有重度抑郁发作。这些诊断之间显著的共病构成了研究长期预后的一个混杂因素。我们对38例“单纯”诊断的患者进行了9年随访,即没有共病恶劣心境和惊恐障碍,这些患者选自两项为期2年的心理治疗和抗抑郁药物自然主义治疗研究。本研究的目的是调查:1)变化的稳定性;2)共病的人格障碍(PDs)对长期预后的影响。通过SCID-I和SCID-II访谈、SCL-90/BSI以及详细的、改良的生活图表访谈对患者进行重新评估,调查病程和随时间的治疗情况。约50%的患者有显著改善,其中约一半病情缓解。共病的PD是一个独立于轴I诊断的不良预后因素。尽管惊恐障碍患者共病PD的频率较低、起病较晚、病程较短且在原研究后预后较好,但长期预后并无差异。惊恐障碍患者预后较不稳定,这表明标准治疗未能带来持久缓解。为了实现缓解,有必要:1)处理共病的PDs;2)对所有共病诊断进行仔细评估;3)建立随访和强化治疗的常规流程。